ECM Coverage Weekly Update (18 August 2018)
Aequitas Research puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. This week, the market was...
721 Views
𝛼SK or SearchENTITY
Hua Medicine (2552 HK)
Hua Medicine (2552 HK)
32
Analysis
Health Care • China
Hua Medicine is an innovative drug development and commercialization company focused on novel therapies for patients with unmet medical needs, particularly in diabetes care. Its cornerstone product is HuaTangNing (dorzagliatin tablets), a first-in-class oral drug for the treatment of Type 2 diabetes. The company was founded in 2011 and is headquartered in Shanghai, China.
morex